Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in pediatric relapsed/refractory acute leukemia
NCT01088984Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of bendamustine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2010; status: completed.
02
Drugs
bendamustine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01088984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088984.